LZTS2 antibody (C-Term)
Quick Overview for LZTS2 antibody (C-Term) (ABIN656926)
Target
See all LZTS2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 572-601, C-Term
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This LZTS2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 572-601 amino acids from the C-terminal region of human LZTS2.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- WB: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- LZTS2 Antibody (C-term) can be refrigerated at 2-8 °C for up to 6 months. For long term storage, place the at -20 °C.
-
Expiry Date
- 6 months
-
-
- LZTS2 (Leucine Zipper, Putative Tumor Suppressor 2 (LZTS2))
-
Alternative Name
- LZTS2
-
Background
- Negative regulator of katanin-mediated microtubule severing and release from the centrosome. Required for central spindle formation and the completion of cytokinesis. May negatively regulate axonal outgrowth by preventing the formation of microtubule bundles that are necessary for transport within the elongating axon. Negative regulator of the Wnt signaling pathway. Represses beta-catenin-mediated transcriptional activation by promoting the nuclear exclusion of beta-catenin.
-
Molecular Weight
- 72759
-
Gene ID
- 84445
-
NCBI Accession
- NP_115805
-
UniProt
- Q9BRK4
Target
-